Insider buying
~$79K39K sh @ $2.04
Traded Oct 1 · filed 5 days later
A major shareholder of Grace Therapeutics paid $79K out of pocket for Grace Therapeutics shares. 1 other person at Grace Therapeutics bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Sep 9, 2026 · Filed Sep 11, 2026
A major shareholder of Grace Therapeutics paid $12K out of pocket for Grace Therapeutics shares. 1 other person at Grace Therapeutics bought some too, in the same month.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$12,197
Shares × reported transaction price
<$25K
+0.2%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
27 days after results of Aug 13, 2026, 64 days before results of Nov 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $2.14 on Sep 9, 2026, within 4% of its 52-week low, after a 5% drop over the previous 30 trading days
52-week range $2.07 (Jul 30, 2026) to $5.13 (Apr 2, 2026), 2% of the way up, from 251 adjusted closes. 30 trading days earlier: $2.25 on Jul 28, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −5.0% | −0.3% | −4.6% |
| 30 days | −9.0% | +1.8% | −10.8% |
Past results only. Not a forecast.
Insider buying
Traded Oct 1 · filed 5 days later
A major shareholder of Grace Therapeutics paid $79K out of pocket for Grace Therapeutics shares. 1 other person at Grace Therapeutics bought some too, in the same month.
Insider buying
Traded Oct 2 · filed 4 days later
A major shareholder of Grace Therapeutics paid $41K out of pocket for Grace Therapeutics shares. 1 other person at Grace Therapeutics bought some too, in the same month.
Insider buying
Traded Oct 5 · filed 1 day later
A major shareholder of Grace Therapeutics paid $3.5K out of pocket for Grace Therapeutics shares. 1 other person at Grace Therapeutics bought some too, in the same month.
Opaleye Management Inc., 10% owner's past purchases, 90 days after disclosure: 64 buys, median +3.2 pts vs S&P 500, beat it 36 of 64 times. Past results, not a forecast.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.